Effect of Jawarish Shahi in Nervous Stomach.

Efficacy of Jawarish Shahi in Irritable Bowel Syndrome â?? An Open Labelled Interventional Clinical Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023790

Enrollment

Registered

2020-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Jawarish Shahi: Jawarish 07 grams orally twice a day with water for duration of 45 days. Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed cases of IBS according to ROME-4 criteria 2.Patients who will give consent and able to do follow up

Exclusion criteria

Exclusion criteria: 1.Patients suffering from systemic illness like Hypertension, DM, Malignancy, Liver or Kidney dysfunction 2.Patients suffering from IBD (Ulcerative colitis, Crohnâ??s disease), Amoebic dysentery, Intestinal tuberculosis or Intestinal obstruction 3.Patients below 18 and above 50 years 4.Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
IBS-Severity Scoring ScaleTimepoint: 0th day, 15th day, 30th day and 45th day.	—

Secondary

Measure	Time frame
IBS-Quality of Life ScoreTimepoint: 0th day, 15th day, 30th day and 45th day	—

Countries

India

Contacts

Public ContactProf Mansoor Ahmad Siddiqui

National Institute of Unani Medicine

mansoorsiddiquidr@gmail.com9448124054

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026